BioSmart Co.,Ltd.
Financials
Valuation Metrics
BioSmart Co.,Ltd.'s Market Cap is ₩708B. At end of 2025 it was ₩986B. Ranked #1481 of 2,436 in KR market (top 61%), #846 of 1,649 on KOSDAQ (top 51%), #127 of 246 in Technology Hardware & Equipment (top 52%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 70.77B KRW | KR#1,481/2,436 Sec#127/246 |
| Revenue | 515.82B KRW | KR#596/2,436 Sec#34/246 |
| Net Income | 13.33B KRW | KR#799/2,436 Sec#66/246 |
| Total Assets | 318.49B KRW | KR#986/2,436 Sec#71/246 |
| Net Assets | 194.90B KRW | KR#940/2,436 Sec#70/246 |
| Employees | 163 | KR#1,246/2,436 Sec#93/246 |
| Value | ||
| P/E | 5.31x | KR#312/2,436 Sec#35/246 |
| P/B | 0.36x | KR#478/2,436 Sec#39/246 |
| PEG | 0.03x | KR#204/2,436 Sec#31/246 |
| P/S | 0.14x | KR#212/2,436 Sec#17/246 |
| EV/EBITDA | 4.76x | KR#210/2,436 Sec#25/246 |
| FCF Yield | -12.96% | KR—/2,436 Sec—/246 |
| Profitability | ||
| ROE | 6.84% | KR#814/2,436 Sec#88/246 |
| ROA | 4.18% | KR#757/2,436 Sec#91/246 |
| Op. Margin | 5.24% | KR#899/2,436 Sec#80/246 |
| Revenue Growth | 29.43% | KR#490/2,436 Sec#63/246 |
| Earnings Growth | 153.17% | KR#313/2,436 Sec#45/246 |
| Financial Health | ||
| Debt Ratio | 163.41% | KR#1,358/2,436 Sec#145/246 |
| Total Debt | 74.01B KRW | KR#824/2,436 Sec#62/246 |
| FCF | -9.17B KRW | KR#1,685/2,436 Sec#167/246 |
| Cash | 16.15B KRW | KR#1,379/2,436 Sec#137/246 |
| Current Ratio | 1.75x | KR#1,119/2,436 Sec#137/246 |
| Net Debt/EBITDA | 2.14x | KR#904/2,436 Sec#93/246 |
| Dividend | ||
| Div. Growth | 290.33% | KR#29/2,436 Sec#5/246 |
| Performance | ||
| 1Y Return | -11.11% | KR#997/2,436 Sec#116/246 |
| 1M Return | 6.26% | KR#405/2,436 Sec#41/246 |
| From 52W High | -59.60% | KR#1,693/2,436 Sec#148/246 |
| 1Y MDD | -62.80% | KR#1,572/2,436 Sec#131/246 |
| Trading | ||
| Volume | 170,694 shares | KR#651/2,436 Sec#72/246 |
| Foreign Own. | 6.99% | KR#618/2,436 Sec#65/246 |
| Per Share | ||
| EPS | 438 KRW | KR#958/2,436 Sec#86/246 |
| BPS | 6,098 KRW | KR#1,291/2,436 Sec#128/246 |
Company Info
Listed on KOSDAQ in 2000, the company is a mid-sized enterprise with five consolidated subsidiaries. It operates businesses in smart cards, pharmaceuticals, alcohol payment, book publishing, diagnostic kits, and heavy electric equipment manufacturing and repair, seeking increased synergy by combining diverse industries. The smart card division leads the domestic IC card and smart card market and has obtained global card company approval. The pharmaceuticals division boasts a portfolio of approximately 300 types of professional and general pharmaceuticals. BIOSMART is headquartered in Seongdong-gu, Seoul.